Lithium Ion

Lithium Ion

SCHEMBL4553780

CN1c2ccccc2CCC1CN.[Al+3].[H-].[H-].[H-].[H-].[Li+]

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 10/20 0.52
HTR2A P28223 1/20 0.41
MEN1 O00255 1/20 0.39
USP2 O75604 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CDK4 P11802 1/20 0.39
ALOX15 P16050 1/20 0.39
CCND1 P24385 1/20 0.39
KMT2A Q03164 1/20 0.39
POLB P06746 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
ACE P12821 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL431801 0.95 MTNR1A (0.56) MTNR1AHTR2AMEN1USP2ALDH1A1
Hydrochloric Acid SCHEMBL6445199 0.94 MTNR1A (0.55) MTNR1AHTR2AMEN1USP2ALDH1A1
SCHEMBL4553781 0.92 MTNR1A (0.53) MTNR1AHTR2AMEN1USP2ALDH1A1
SCHEMBL22298024 0.80 MTNR1A (0.61) MTNR1AMEN1USP2ALDH1A1CDK4
SCHEMBL22364516 0.80 MTNR1A (0.61) MTNR1AMEN1USP2ALDH1A1CDK4
SCHEMBL19046964 0.79 MTNR1A (0.53) MTNR1AMEN1USP2ALDH1A1CDK4
SCHEMBL21890123 0.79 MTNR1A (0.53) MTNR1AMEN1USP2ALDH1A1CDK4
SCHEMBL19047007 0.79 MTNR1A (0.53) MTNR1AMEN1USP2ALDH1A1CDK4
SCHEMBL9470084 0.79 MTNR1A (0.59) MTNR1AHTR2AMEN1USP2ALDH1A1
SCHEMBL21081149 0.78 MTNR1A (0.58) MTNR1AMEN1USP2ALDH1A1CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2134678-A2 N-(5, 6, 7, 8-TETRAHYDRONAPHTHALEN-1-YL) UREA DERIVATIVES AND RELATED COMPOUNDS AS TRPV1 VANILLOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PAIN Abbott Laboratories (US) 2009-12-23 EP disclosed
WO-2008079683-A2 N- (5, 6, 7, 8-TETRAHYDRONAPHTHALEN-1-YL) UREA DERIVATIVES AND RELATED COMPOUNDS AS TRPV1 VANILLOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PAIN ABBOTT LABORATORIES (US) 2008-07-03 WO disclosed